IQVIA to announce Q2FY26 results on July 28, 2026
IQVIA Holdings Inc. will announce its Q2FY26 financial results on July 28, 2026, before the market opens. A conference call and webcast are scheduled for 9:00 a.m. ET the same day, with registration required for participation. The earnings release and webcast replay will be available on the company's Investor Relations website.

*this image is generated using AI for illustrative purposes only.
IQVIA Holdings Inc. will announce its second-quarter 2026 financial results before the market opens on Tuesday, July 28, 2026. The company, a global provider of clinical research services and healthcare intelligence, will host a conference call and webcast at 9:00 a.m. Eastern Time the same day to discuss the performance. The earnings release and accompanying financial information will be posted on the IQVIA Investor Relations website at http://ir.iqvia.com .
Conference Call Details
Interested parties must register in advance to participate in the conference call. Registration can be completed at http://ir.iqvia.com . Upon registration, participants will receive a confirmation email containing dial-in details, a unique passcode, and a registrant ID. Registered participants can join the call directly using the information provided in the confirmation email.
Webcast and Replay
The webcast will be accessible via the IQVIA Investor Relations website. A replay of the webcast will be available approximately two hours after the conclusion of the live event. Investors can access the recording at http://ir.iqvia.com .
Key Event Information
| Event | Date | Time |
|---|---|---|
| Q2FY26 Results Announcement | July 28, 2026 | Before market open |
| Conference Call and Webcast | July 28, 2026 | 9:00 a.m. ET |
| Webcast Replay Availability | July 28, 2026 | Approx. 2 hours post-event |
IQVIA provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries. The company employs approximately 93,000 people in over 100 countries.
What are the expected key financial metrics and guidance updates for the second quarter of 2026?
How might IQVIA's performance in Q2FY26 reflect broader trends in the clinical research and healthcare intelligence sectors?
What strategic initiatives or partnerships could IQVIA announce during the earnings call to drive future growth?


























